Stocks
AxoGen Financial Statements (AXGN) |
||||||||||
| AxoGensmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.03.2021 | 25.02.2022 | 30.09.2022 | 14.03.2023 | 05.03.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 112.3 | 127.4 | 138.6 | 159.0 | 163.7 | ||||
| Operating Income, bln rub | -23.2 | -25.4 | -29.7 | -21.5 | -18.7 | |||||
| EBITDA, bln rub | ? | -19.8 | -21.0 | -25.1 | -15.9 | -12.8 | ||||
| Net profit, bln rub | ? | -24.8 | -28.1 | -27.3 | -21.7 | -21.3 | ||||
| OCF, bln rub | ? | -9.63 | -13.4 | -16.1 | -5.72 | -10.6 | ||||
| CAPEX, bln rub | ? | 22.6 | 28.4 | 21.3 | 14.9 | 11.7 | ||||
| FCF, bln rub | ? | -32.2 | -41.8 | -37.3 | -20.6 | -22.3 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 113.9 | 129.8 | 144.1 | 149.3 | 149.2 | |||||
| Cost of production, bln rub | 21.6 | 22.9 | 24.1 | 31.1 | 33.2 | |||||
| R&D, bln rub | 17.8 | 24.2 | 27.2 | 28.3 | 29.1 | |||||
| Interest expenses, bln rub | 1.05 | 1.36 | 0.624 | 8.12 | 5.19 | |||||
| Assets, bln rub | 201.4 | 208.0 | 195.5 | 195.4 | 196.8 | 186.5 | ||||
| Net Assets, bln rub | ? | 123.1 | 112.6 | 101.4 | 101.0 | 95.7 | 93.2 | |||
| Debt, bln rub | 53.8 | 67.5 | 67.7 | 67.4 | 69.3 | 69.2 | ||||
| Cash, bln rub | 104.0 | 84.1 | 53.1 | 48.8 | 37.0 | 23.6 | ||||
| Net debt, bln rub | -50.2 | -16.6 | 14.5 | 18.6 | 32.3 | 45.5 | ||||
| Ordinary share price, rub | 17.9 | 9.37 | 11.9 | 9.98 | 6.83 | 3.79 | ||||
| Number of ordinary shares, mln | 40.0 | 41.2 | 42.1 | 42.9 | 43.2 | |||||
| Market cap, bln rub | 715 | 386 | 0 | 420 | 293 | 164 | ||||
| EV, bln rub | ? | 665 | 370 | 15 | 439 | 325 | 209 | |||
| Book value, bln rub | 121 | 110 | 98 | 97 | 91 | 88 | ||||
| EPS, rub | ? | -0.62 | -0.68 | -0.65 | -0.51 | -0.49 | ||||
| FCF/share, rub | -0.81 | -1.01 | -0.89 | -0.48 | -0.51 | |||||
| BV/share, rub | 3.03 | 2.66 | 2.31 | 2.13 | 2.04 | |||||
| EBITDA margin, % | ? | -17.6% | -16.5% | -18.1% | -10.0% | -7.79% | ||||
| Net margin, % | ? | -22.1% | -22.0% | -19.7% | -13.7% | -13.0% | ||||
| FCF yield, % | ? | -4.50% | -10.8% | 0.00% | -8.89% | -7.05% | -13.6% | |||
| ROE, % | ? | -20.1% | -24.9% | 0.00% | -27.1% | -22.7% | -22.8% | |||
| ROA, % | ? | -12.3% | -13.5% | 0.00% | -14.0% | -11.0% | -11.4% | |||
| P/E | ? | -28.8 | -13.8 | -15.4 | -13.5 | -7.70 | ||||
| P/FCF | -22.2 | -9.24 | -11.3 | -14.2 | -7.36 | |||||
| P/S | ? | 6.37 | 3.03 | 3.03 | 1.84 | 1.00 | ||||
| P/BV | ? | 5.91 | 3.52 | 0.00 | 4.31 | 3.21 | 1.85 | |||
| EV/EBITDA | ? | -33.7 | -17.6 | -17.5 | -20.4 | -16.4 | ||||
| Debt/EBITDA | 2.54 | 0.79 | -0.74 | -2.03 | -3.57 | |||||
| R&D/CAPEX, % | 79.0% | 85.1% | 127.8% | 189.9% | 248.4% | |||||
| CAPEX/Revenue, % | 20.1% | 22.3% | 15.3% | 9.38% | 7.15% | |||||
| AxoGen shareholders | ||||||||||
